fbpx

Systematic Review of Biological Treatments for Cartilage Repair

Systematic Review of Biological Treatments for Cartilage Repair

April 24,2018

Macquarie Stem Cells has provided this information to educate the public based on peer reviewed, published scientific and medical documents. We don’t aim to encourage consumers to seek out such treatments prior to an assessment by a health professional to determine your suitability for treatment. This is obtained directly from NCBI Pubmed Literature. This study has received funding from Osiris Therapeutics, Inc. We aim to provide you with an unbiased range of treatments that are available aside from biological therapy, this is discussed in ‘supporting information>other-options’  page on our website

Published: Current Stem Cell Research & Therapy Journal – 2018

TITLE: “A systematic review and meta-analysis of clinical trials of mesenchymal stem cell therapy for cartilage repair.” (Borakati et al., 2018)

Review Published 23rd of February 2018

BACKGROUND:

“Osteoarthritis (OA) is a major global burden creating significant morbidity worldwide. Current curative therapies are expensive, challenging to access and have significant risks, making them infeasible and difficult in many cases. Mesenchymal stem cells (MSCs) can be applied to joints and may regenerate the cartilage damaged in OA, this therapy may be advantageous to existing treatments.” (Borakati et al., 2018)

OBJECTIVE:

“We systematically reviewed clinical trials of MSCs for cartilage repair and provide an overview of the literature in this area here. MEDLINE, Embase, CENTRAL, clinicaltrials.gov and Open- Grey were searched for controlled trials and case series with >5 patents involving MSC therapy for cartilage repair. The controlled trials were meta-analysed and the primary outcome measure was improvement in pain over the control group. A narrative synthesis was composed for the case series.” (Borakati et al., 2018)

RESULTS:

“A significant reduction in pain was found with the use of MSCs over controls: Standardised mean difference=-1.27 (95% Confidence intervals -1.95 to -0.58). However, the data was extremely heterogeneous with I2=95%, this may be attributed to differing therapies, clinical indication for treatment and joints treated amongst others. Case series showed improvements in treated patients with a variety of differing treatments and by many outcomes. There were no severe adverse outcomes found across all studies that could be attributed to MSCs, implying their safety.” (Borakati et al., 2018)

CONCLUSION:

“We conclude that MSCs have significant potential for the treatment of OA, however, larger, more consistent trials are needed for conclusive analysis. (Borakati et al., 2018)

REF: Borakati, A., Mafi, R., Mafi, P. and Khan, W. (2018). A Systematic Review And Meta-Analysis of Clinical Trials of Mesenchymal Stem Cell Therapy for Cartilage Repair. Current Stem Cell Research & Therapy, 13(3), pp.215-225.

Tags: Macquarie Stem Cells, Dr. Bright, Osteoarthritis Treatment, Dr. Ralph Bright,Biological Therapy, Biological Treatment, Biologicals for Arthritis, 

 

Remember, any surgical or invasive procedure carries risks. Before proceeding, you should seek a second opinion from an appropriately qualified health practitioner.

Speak with one of our consultants today